Inventor
TEUTSCH JEAN-GEORGES
FR50 patents
⚠️ This page may combine multiple inventors who share the name “TEUTSCH JEAN-GEORGES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROUSSEL UCLAF
28 patentsUS5434176AJul 18, 1995
Phenylimidazolidines
ROUSSEL UCLAF109 citations99
US5411981AMay 2, 1995
Phenylimidazolidines having antiandrogenic activity
ROUSSEL UCLAF183 citations98
US5705654AJan 6, 1998
Imidazolidines substituted with a heterocycle
ROUSSEL UCLAF60 citations96
US5646172AJul 8, 1997
Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle
ROUSSEL UCLAF57 citations96
US5556983ASep 17, 1996
Phenylimidazolidines
ROUSSEL UCLAF69 citations96
US5627201AMay 6, 1997
Phenylimidazolidines having antiandrogenic activity
ROUSSEL UCLAF74 citations95
US5589497ADec 31, 1996
Phenylimidazolidines
ROUSSEL UCLAF57 citations93
USRE35956ENov 10, 1998
Phenylimidazolidines having antiandrogenic activity
ROUSSEL UCLAF57 citations92
US5494907AFeb 27, 1996
11-β substituted-19-nor steroids
ROUSSEL UCLAF19 citations92
US4912097AMar 27, 1990
Novel 11 β-alkynylphenyl-10-nor-steroids
ROUSSEL UCLAF46 citations92
US4753932AJun 28, 1988
Novel 10-substituted steroids
ROUSSEL UCLAF43 citations92
US4634696AJan 6, 1987
Novel 11 beta-substituted-19-nor-steroids
ROUSSEL UCLAF25 citations92
US4547493AOct 15, 1985
Novel 11β-substituted-19-nor-steroids
ROUSSEL UCLAF35 citations92
US5827887AOct 27, 1998
Biphenyl compounds
ROUSSEL UCLAF30 citations89
US5043332AAug 27, 1991
Novel 11β-substituted -19-nor-steriods
ROUSSEL UCLAF20 citations82
US4978657ADec 18, 1990
Novel 11β-substituted-19-nor-steroids
ROUSSEL UCLAF22 citations82
US5705494AJan 6, 1998
Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids
ROUSSEL UCLAF9 citations74
US5679788AOct 21, 1997
11 beta-substituted-19 nor-steroids
ROUSSEL UCLAF9 citations74
US5385897AJan 31, 1995
4-thia-1-aza-bicyclo[4,2,0]oct-2-ene derivatives
ROUSSEL UCLAF8 citations73
US5378697AJan 3, 1995
Cephalosporins
ROUSSEL UCLAF5 citations73
US5525594AJun 11, 1996
Treatment of hyperandrogenic disorders
ROUSSEL UCLAF10 citations70
US5556845ASep 17, 1996
11-β substituted-19-nor steroids
ROUSSEL UCLAF9 citations69
US5683996ANov 4, 1997
4-thia-1-aza-bicyclo 4,2,0!oct-2-ene antibiotics
ROUSSEL UCLAF2 citations62
US5538963AJul 23, 1996
Cephalosporins
ROUSSEL UCLAF2 citations62
US5621095AApr 15, 1997
Cephalosporins
ROUSSEL UCLAF1 citations61
US4908359AMar 13, 1990
1-dethia-2-thia-cephalosporanic acids
ROUSSEL UCLAF4 citations61
US5707982AJan 13, 1998
19-nor-steroids
ROUSSEL UCLAF0 citations42
US5663164ASep 2, 1997
1-dethia-2-thia-cephalosporanic acids
ROUSSEL UCLAF0 citations41
AVENTIS PHARMA SA
13 patentsUS6288126B1Sep 11, 2001
Biphenyl compounds and use thereof as oestrogenic agents
AVENTIS PHARMA SA23 citations92
US6492536B2Dec 10, 2002
Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them
AVENTIS PHARMA SA5 citations70
US6790971B1Sep 14, 2004
19-Nor-steroids
AVENTIS PHARMA SA4 citations63
US6596885B2Jul 22, 2003
19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions
AVENTIS PHARMA SA4 citations63
US6563008B2May 13, 2003
Biphenyl compounds and their use as oestrogenic agents
AVENTIS PHARMA SA2 citations63
US6482813B1Nov 19, 2002
Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them
AVENTIS PHARMA SA2 citations62
US6399766B2Jun 4, 2002
4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
AVENTIS PHARMA SA1 citations62
US6794415B2Sep 21, 2004
Biphenyl compounds and their use as oestrogenic agents
AVENTIS PHARMA SA1 citations52
US6541464B2Apr 1, 2003
Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them
AVENTIS PHARMA SA0 citations51
US6472382B2Oct 29, 2002
4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
AVENTIS PHARMA SA0 citations51
US6462211B1Oct 8, 2002
4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
AVENTIS PHARMA SA0 citations51
US6274572B1Aug 14, 2001
Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
AVENTIS PHARMA SA0 citations49
US6459001B1Oct 1, 2002
Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
AVENTIS PHARMA SA0 citations41
HOECHST MARION ROUSSEL INC
7 patentsUS6242611B1Jun 5, 2001
Phenylimidazolidines containing nitrooxy or carbonyloxy groups
HOECHST MARION ROUSSEL INC66 citations96
US5958936ASep 28, 1999
Imidazolidines substituted with a heterocycle
HOECHST MARION ROUSSEL INC46 citations96
US6221907B1Apr 24, 2001
Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
HOECHST MARION ROUSSEL INC16 citations83
US6239121B1May 29, 2001
4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
HOECHST MARION ROUSSEL INC4 citations73
US6207657B1Mar 27, 2001
Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them
HOECHST MARION ROUSSEL INC3 citations62
US5981516ANov 9, 1999
Method of treating menopause or perimenopause
HOECHST MARION ROUSSEL INC5 citations62
US5965763AOct 12, 1999
Biphenyl compounds
HOECHST MARION ROUSSEL INC1 citations52